New Rhein Healthcare Investors
Overview
New Rhein Healthcare Investors is a venture capital firm that applies a private equity business model to life sciences investing, focusing on assets with proven clinical safety and efficacy. The firm takes significant stakes in a small number of companies and actively manages their value creation. It invests in pharmaceutical, healthcare, and medical device companies with clinical-stage assets across the United States and Europe. New Rhein invests broadly across all therapeutic areas, including Alzheimer's, respiratory disease, urology, and migraine.
Portfolio Companies
6
Website
newrhein.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Neuraptive Therapeutics | Dec 2018 | Series A | Lead |
| Alveus Therapeutics | Feb 2026 | Series A Extension | Lead |
| Corsair Pharma | Sep 2023 | Series B | Lead |
| Butterfly Medical | May 2026 | Series C | Co-investor |
| Theranica | Aug 2022 | Series C | Lead |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is New Rhein Healthcare Investors based?
New Rhein Healthcare Investors is headquartered in Philadelphia, Pennsylvania, United States.
When was New Rhein Healthcare Investors founded?
Founding year information for New Rhein Healthcare Investors is not publicly available.
How many portfolio companies does New Rhein Healthcare Investors have?
New Rhein Healthcare Investors has 6 portfolio companies in Caplight's dataset.
What are some companies in New Rhein Healthcare Investors's portfolio?
Portfolio companies visible on Caplight include Neuraptive Therapeutics, Alveus Therapeutics, Corsair Pharma, Butterfly Medical, Theranica.
What was New Rhein Healthcare Investors's most recent investment shown here?
New Rhein Healthcare Investors's most recent investment in this portfolio sample was in Butterfly Medical in 2026.
What sectors does New Rhein Healthcare Investors focus on?
New Rhein Healthcare Investors focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences.
What company stages does New Rhein Healthcare Investors focus on?
New Rhein Healthcare Investors typically invests at the Early stage.
What is New Rhein Healthcare Investors's AUM?
New Rhein Healthcare Investors's assets under management are estimated between $263.8M and $263.8M.